Montreal, Quebec–(Newsfile Corp. – August 17, 2026) – Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (“Defence” or the “Company”), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® technology, is pleased to announce the appointment of Ryan Simms, PhD, as Chief Operating Officer (“COO”) and …
Read More »
Breaking News
- New Company Crash.gg Launches Human-First Workforce Model to Challenge the AI Automation Trend
- Rise Nano Optics Joins the Vision Council, a Leading Optical Trade Association, Expanding Access to Key Optical Relationship
- Grande Portage Resources Receives State of Alaska Regulatory Clearance for Road Easement
- Silver Pony Announces OTC Symbol Change to PONIF Following Name Change
- Provenance Gold Commences Drilling at Its Eldorado West Project
- Myriad Uranium Announces Preliminary Radiometric Results from Lucky Cliff Drilling
- Group Eleven Cuts Deeper Cu-Ag Mineralization in 710m Step-Out; Drills 3.7m of 7.7% Zn+Pb, 418 g/t Ag and 1.02% Cu in a Wider 17.6m Interval; Returns Mineralization in First Hole at ‘Anomaly A’
- Vortex Metals Engages Global Frontier Advisors and Appoints Ambassador Roberta Jacobson and Ambassador James Story to Advisory Board
- Heliostar Samples High Grade Antimony with Gold and Commences Drilling at Goldstrike Project, Utah
- WELL Health Redeems $70 Million 5.50% Convertible Debentures
Matribhumi Samachar
Address : 125 - Rajiv Nagar, Vinayakpur, Kanpur - 208025
Mo. No.: 8303063085
Email: [email protected]
Managed By Y2KSOLUTION
Copyright © Matribhumi Samachar